OBJECTIVES: The effects of age at diagnosis on the clinical characteristics of breast cancer and trends over time were investigated in Chinese women. METHODS: Data from 4211 women with pathologically confirmed primary breast cancer collected between 1999 and 2008 for a multicentre retrospective study were analysed according to age at diagnosis. RESULTS: Age at diagnosis ranged from 21 to 86 years, with a mean of 48.7 years, and was shown to be significantly related to tumour size, lymph node status, hormone receptor status and human growth factor receptor-2 status, but not to pathological type or tumour, node, metastasis stage. The age-corrected proportion of patients aged 50 – 64 years at diagnosis increased significantly between 1999 and 2008. There was a significant difference in the age-corrected distribution of age at diagnosis in China compared with Western countries. CONCLUSIONS: Age at diagnosis is related to the clinical and pathological characteristics of breast cancer. The age at diagnosis in China increased over the decade from 1999 to 2008, but is still lower than in Western countries.
JemalABrayFCenterMM: Global cancer statistics. CA Cancer J Clin2011; 61: 69–90.
2.
AndersonWFJatoiIShermanME: Qualitative age interactions in breast cancer studies: mind the gap. J Clin Oncol2009; 27: 5308–5311.
3.
JatoiIAndersonWF: Qualitative age interactions in breast cancer studies: A mini-review. Future Oncol2010; 6: 1781–1788.
4.
BeadleBMWoodwardWABuchholzTA: The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol2011; 21: 26–34.
5.
International Agency for Research on Cancer, World Health Organization (WHO): GLOBOCAN 2008, Cancer Incidence, Mortality and Prevalence Worldwide in 2008. Geneva: WHO (available at: http://globocan.iarc.fr/).
6.
ParkinDMWhelanSLFerlayJ, (eds): Cancer Incidence in Five Continents, Vols I—VIII, IARC CancerBase No. 7. Lyon: IARC, 2005.
7.
ShenYCChangCJHsuC: Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age—period—cohort analysis. Cancer Epidemiol Biomarkers Prev2005; 14: 1986–1990.
8.
LeungGMThachTQLamTH: Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age—period—cohort analysis. Br J Cancer2002; 87: 982–988.
9.
LuWLLiHXQianBY: The clinical characteristics and prognosis of Chinese early stage breast cancer patients: A retrospective study. Breast J2010; 16: 331–333.
10.
FanLZhengYYuKD: Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat2009; 117: 409–416.
11.
KuoWHYenAMLeePH: Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women. Br J Cancer2009; 100: 563–570.
12.
LiuYTGaoCMDingJH: Physiological, reproductive factors and breast cancer risk in Jiangsu Province of China. Asian Pac J Cancer Prev2011; 12: 787–790.
13.
SimXAliRAWedrenS: Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968–2002. BMC Cancer2006; 6: 261.
14.
LeeJHYimSH, Won YJ, et al, for Members of Korean Breast Cancer Society (KBCS): Population-based breast cancer statistics in Korea during 1993–2002: incidence, mortality, and survival. J Korean Med Sci2007; 22 (suppl): S11–S16.
15.
MinamiYTsubonoYNishinoY: The increase of female breast cancer incidence in Japan: emergence of birth cohort effect. Int J Cancer2004; 108: 901–906.
16.
JemalACenterMMDeSantisC: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev2010; 19: 1893–1907.
17.
ColditzGASellersTATrapidoE: Epidemiology—identifying the causes and preventability of cancer?Nat Rev Cancer2006; 6: 75–83.
18.
ItoYIokaATanakaM: Trends in cancer incidence and mortality in Osaka, Japan: evaluation of cancer control activities. Cancer Sci2009; 100: 2390–2395.
19.
HutchinsLFUngerJMCrowleyJJ: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med1999; 341: 2061–2067.
20.
LiJZhangBNFanJH: A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer2011; 11: 364.
21.
ZhengSBaiJQLiJ: The pathologic characteristics of breast cancer in China and its shift during 1999–2008: A national-wide multicenter cross-sectional image over 10 years. Int J Cancer2012; epub ahead of print.
National Cancer Institute: Surveillance, Epidemiology, and End Results. Overview of the SEER Program. Bethesda: National Cancer Institute, National Institutes of Health (available at: http://seer.cancer.gov/about/).
AndersonWFJatoiIDevesaSS: Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat2005; 90: 127–137.
27.
ZabickiKColbertJADominguezFJ: Breast cancer diagnosis in women ≤ 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol2006; 13: 1072–1077.
28.
KimJKKwakBSLeeJS: Do very young Korean breast cancer patients have worse outcomes?Ann Surg Oncol2007; 14: 3385–3391.
29.
CancelloGMaisonneuvePRotmenszN: Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (< 35 years) with operable breast cancer. Ann Oncol2010; 10: 1974–1981.
30.
BauerKRBrownMCressRD: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California Cancer Registry. Cancer2007; 109: 1721–1728.
31.
YoshidaMShimizuCFukutomiT: Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis. Jpn J Clin Oncol2011; 41: 180–189.
32.
FooCSSuDChongCK: Breast cancer in young Asian women: study on survival. ANZ J Surg2005; 75: 566–572.
33.
ZhouPRechtA: Young age and outcome for women with early-stage invasive breast carcinoma. Cancer2004; 101: 1264–1274.
34.
GoldhirschAWoodWCGelberRD: Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol2007; 18: 1133–1144.
35.
VielJFRymzhanovaRFournier: Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age—period—cohort analysis. Cancer Epidemiol2011; 35: 521–525.
